DOI: 10.11958/20193736
Salubrinal treats the non-alcoholic fatty liver disease through eIF2α signaling pathway
ZHANG Shi-qi
LIU Da-quan
LI Xin-le
ZHANG Ping
Machine-generated Keywords：
Publication Date：2020-05-15
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 375-380 )